Literature DB >> 23526039

Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study.

Jeannette T Bensen1, Chiu Kit Tse, Sarah J Nyante, Jill S Barnholtz-Sloan, Stephen R Cole, Robert C Millikan.   

Abstract

PURPOSE: Common germline variation in the 5' region proximal to precursor (pre-) miRNA gene sequences is evaluated for association with breast cancer risk and survival among African Americans and Caucasians.
METHODS: We genotyped nine single nucleotide polymorphisms (SNPs) within six miRNA gene regions previously associated with breast cancer, in 1,972 cases and 1,776 controls. In a race-stratified analysis using unconditional logistic regression, odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated to evaluate SNP association with breast cancer risk. Additionally, hazard ratios (HRs) for breast cancer-specific mortality were estimated.
RESULTS: Two miR-185 SNPs provided suggestive evidence of an inverse association with breast cancer risk (rs2008591, OR = 0.72 (95 % CI = 0.53-0.98, p value = 0.04) and rs887205, OR = 0.71 (95 % CI = 0.52-0.96, p value = 0.03), respectively) among African Americans. Two SNPs, miR-34b/34c (rs4938723, HR = 0.57 (95 % CI = 0.37-0.89, p value = 0.01)) and miR-206 (rs6920648, HR = 0.77 (95 % CI = 0.61-0.97, p value = 0.02)), provided evidence of association with breast cancer survival. Further adjustment for stage resulted in more modest associations with survival (HR = 0.65 [95 % CI = 0.42-1.02, p value = 0.06] and HR = 0.79 [95 % CI = 0.62-1.00, p value = 0.05, respectively]).
CONCLUSIONS: Our results suggest that germline variation in the 5' region proximal to pre-miRNA gene sequences may be associated with breast cancer risk among African Americans and breast cancer-specific survival generally; however, further validation is needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23526039      PMCID: PMC3804004          DOI: 10.1007/s10552-013-0187-z

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  61 in total

1.  Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.

Authors:  L Beviglia; K Matsumoto; C S Lin; B L Ziober; R H Kramer
Journal:  Int J Cancer       Date:  1997-06-20       Impact factor: 7.396

2.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

3.  Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study.

Authors:  Dominik J Jedlinski; Plamena N Gabrovska; Stephen R Weinstein; Robert A Smith; Lyn R Griffiths
Journal:  Twin Res Hum Genet       Date:  2011-10       Impact factor: 1.587

4.  A general framework for studying genetic effects and gene-environment interactions with missing data.

Authors:  Y J Hu; D Y Lin; D Zeng
Journal:  Biostatistics       Date:  2010-03-26       Impact factor: 5.899

5.  Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

Authors:  Valery Tarasov; Peter Jung; Berlinda Verdoodt; Dmitri Lodygin; Alexey Epanchintsev; Antje Menssen; Gunter Meister; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-05-11       Impact factor: 4.534

6.  Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women.

Authors:  Zhibin Hu; Jie Liang; Zhanwei Wang; Tian Tian; Xiaoyi Zhou; Jiaping Chen; Ruifen Miao; Yan Wang; Xinru Wang; Hongbing Shen
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

7.  Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.

Authors:  Annika Brendle; Haixin Lei; Andreas Brandt; Robert Johansson; Kerstin Enquist; Roger Henriksson; Kari Hemminki; Per Lenner; Asta Försti
Journal:  Carcinogenesis       Date:  2008-06-10       Impact factor: 4.944

8.  microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.

Authors:  Francesca M Buffa; Carme Camps; Laura Winchester; Cameron E Snell; Harriet E Gee; Helen Sheldon; Marian Taylor; Adrian L Harris; Jiannis Ragoussis
Journal:  Cancer Res       Date:  2011-07-07       Impact factor: 12.701

9.  Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells.

Authors:  Hao Liu; You-De Cao; Wei-Xia Ye; Yang-Yang Sun
Journal:  Tumori       Date:  2010 Sep-Oct

10.  Atypical transcription of microRNA gene fragments.

Authors:  Jin Song Gao; Yingjie Zhang; Ming Li; Lynne D Tucker; Jason T Machan; Peter Quesenberry; Isidore Rigoutsos; Bharat Ramratnam
Journal:  Nucleic Acids Res       Date:  2010-01-21       Impact factor: 16.971

View more
  39 in total

1.  Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.

Authors:  Zhenzhen Wu; Peng Wang; Chunhua Song; Kaijuan Wang; Rui Yan; Jingruo Li; Liping Dai
Journal:  Mol Genet Genomics       Date:  2015-01-09       Impact factor: 3.291

2.  Genetic variations at microRNA and processing genes and risk of oral cancer.

Authors:  Roshni Roy; Navonil De Sarkar; Sandip Ghose; Ranjan R Paul; Mousumi Pal; Chandrika Bhattacharya; Shweta K Roy Chowdhury; Saurabh Ghosh; Bidyut Roy
Journal:  Tumour Biol       Date:  2013-12-03

3.  Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake.

Authors:  Muhua Yang; Weidong Liu; Christina Pellicane; Christine Sahyoun; Biny K Joseph; Christina Gallo-Ebert; Melissa Donigan; Devanshi Pandya; Caroline Giordano; Adam Bata; Joseph T Nickels
Journal:  J Lipid Res       Date:  2013-12-02       Impact factor: 5.922

4.  Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.

Authors:  Sara Sanaei; Mohammad Hashemi; Maryam Rezaei; Seyed Mehdi Hashemi; Gholamreza Bahari; Saeid Ghavami
Journal:  Biomed Rep       Date:  2016-05-23

5.  miR-185 mediates lung epithelial cell death after oxidative stress.

Authors:  Duo Zhang; Heedoo Lee; Yong Cao; Charles S Dela Cruz; Yang Jin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

6.  Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls.

Authors:  Tao Tao; Shuqiu Chen; Bin Xu; Chunhui Liu; Yiduo Wang; Yeqing Huang; Ming Chen
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

7.  In silico analysis of polymorphisms in microRNAs that target genes affecting aerobic glycolysis.

Authors:  Padmanaban S Suresh; Thejaswini Venkatesh; Rie Tsutsumi
Journal:  Ann Transl Med       Date:  2016-02

8.  Dysregulation of microRNA-34a expression in colorectal cancer inhibits the phosphorylation of FAK via VEGF.

Authors:  Danhua Zhang; Jianping Zhou; Ming Dong
Journal:  Dig Dis Sci       Date:  2013-12-27       Impact factor: 3.199

9.  Function analysis of rs9589207 polymorphism in miR-92a in gastric cancer.

Authors:  Changming Liu; Ying Zhang; Haijun Chen; Lixing Jiang; Daping Xiao
Journal:  Tumour Biol       Date:  2015-10-25

10.  Integrating biology and access to care in addressing breast cancer disparities: 25 years' research experience in the Carolina Breast Cancer Study.

Authors:  Marc A Emerson; Katherine E Reeder-Hayes; Heather J Tipaldos; Mary E Bell; Marina R Sweeney; Lisa A Carey; H Shelton Earp; Andrew F Olshan; Melissa A Troester
Journal:  Curr Breast Cancer Rep       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.